How is renovascular hypertension diagnosed?

Diagnosis of Renovascular Hypertension

For patients with suspected renovascular hypertension and normal renal function, start with renal duplex Doppler ultrasound as the first-line screening test, followed by MRA without contrast or CTA with contrast if ultrasound is inconclusive or technically limited. 1

Clinical Suspicion: When to Investigate

Before ordering imaging, ensure the patient has clinical features that warrant investigation for renovascular hypertension 1:

• Abdominal bruit (systolic-diastolic)
• Severe hypertension (diastolic >110 mmHg) in young adults (<35 years)
• New-onset hypertension after age 50
• Sudden worsening of previously controlled hypertension
• Refractory hypertension despite multiple medications
• Acute kidney injury after starting ACE inhibitors or ARBs
• Generalized atherosclerotic disease with hypertension
• Flash pulmonary edema with hypertension

Diagnostic Algorithm Based on Renal Function

Normal Renal Function (eGFR ≥30 mL/min/1.73 m²)

First-line: Renal Duplex Doppler Ultrasound (Rating: 9/9 - "usually appropriate") 1

• Advantages: No radiation, no contrast, can be used regardless of renal function
• Key parameters:
  • Peak systolic velocity (PSV) ≥200 cm/s (sensitivity 91%, specificity 75-96%)
  • Renal artery-to-aortic ratio (RAR) ≥3.5
• Limitations: Operator-dependent, limited by body habitus, bowel gas, and inability to visualize accessory renal arteries

Second-line options if ultrasound is inconclusive:

• MRA without IV contrast (Rating: 7/9) 1 - excellent for fibromuscular dysplasia, no radiation
• CTA with IV contrast (Rating: 5/9) 1 - superior spatial resolution, but involves radiation and contrast

Decreased Renal Function (eGFR <30 mL/min/1.73 m²)

First-line: Renal Duplex Doppler Ultrasound (Rating: 9/9) 1

• Same technique as above, but becomes even more critical as the safest option

Second-line: MRA without IV contrast (Rating: 7/9) 1

• Critical: Avoid gadolinium contrast due to nephrogenic systemic fibrosis risk
• Use noncontrast MRI protocols

CTA with contrast drops to Rating 5/9 in this population 1 due to contrast-induced nephropathy concerns, though recent evidence suggests lower risk than previously thought 1

Modalities to Avoid as Screening Tests

• Tc-99m ACE-inhibitor renography: Rating 3/9 1 - decreased accuracy with bilateral disease or impaired renal function
• Conventional angiography: Rating 3/9 1 - reserved for confirmation and intervention, not screening
• Renal vein sampling: Rating 3/9 1 - invasive, not useful for diagnosis

Important Caveats

Anatomic stenosis ≠ renovascular hypertension: Finding renal artery stenosis on imaging does not confirm it's causing the hypertension. The gold standard remains blood pressure improvement after intervention (angioplasty, stenting, or surgery) 1. Most studies define significant stenosis as ≥60-70% narrowing, though perfusion pressure typically isn't reduced until stenosis exceeds 70-75% 1.

Bilateral disease is problematic: Difficult to determine which side is contributing to hypertension, and functional testing becomes less reliable 1.

Technical failures: Ultrasound has high failure rates in obese patients or those with significant bowel gas. Don't hesitate to proceed directly to CTA or MRA in these patients 1.

Practical Workflow

1. Identify high-risk clinical features (see list above)
2. Check renal function (eGFR)
3. Order renal duplex Doppler ultrasound as initial test
4. If ultrasound is technically inadequate or equivocal:
   • Normal renal function → MRA without contrast or CTA with contrast
   • Impaired renal function → MRA without contrast only
5. Reserve angiography for patients being considered for revascularization

This algorithmic approach prioritizes patient safety (avoiding contrast in renal impairment), cost-effectiveness (ultrasound first), and diagnostic accuracy while recognizing that imaging alone cannot definitively establish causation 1.